Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
28%
OVERLAP
BY WEIGHT
7
# OF OVERLAPPING
HOLDINGS
HRTS
42
HOLDINGS
17%
ALSO IN PPH
PPH
27
HOLDINGS
30%
ALSO IN HRTS
SECTOR DRIFT (HRTS minus PPH)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HRTS |
Weight in PPH |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 19.1% | 10.2% |
|
JOHNSON & JOHNSON | 4.8% | 4.7% | 4.7% |
|
MERCK & CO. INC. | 4.2% | 9.6% | 4.2% |
|
ABBVIE INC | 2.9% | 4.0% | 2.9% |
|
BRISTOL-MYERS SQUIBB CO | 2.2% | 4.9% | 2.2% |
HRTS Overweight Relative to PPH
 |
ROCHE HOLDINGS LTD-SPONS ADR | 5.4% |
 |
ASTRAZENECA PLC | 4.4% |
|
THERMO FISHER SCIENTIFIC INC | 4.1% |
|
GILEAD SCIENCES INC | 3.8% |
|
UNITEDHEALTH GROUP INC | 3.7% |
|
NOVARTIS AG | 3.3% |
|
ABBOTT LABORATORIES | 3.3% |
|
DANAHER CORP | 3.0% |
 |
MEDTRONIC PLC | 3.0% |
|
VERTEX PHARMACEUTICALS INC | 2.9% |
HRTS Underweight Relative to PPH
|
NOVARTIS AG-ADR | -10.6% |
|
ELI LILLY & CO | -8.9% |
 |
NOVO-NORDISK A/S-SPONS ADR | -5.6% |
|
MERCK & CO. INC. | -5.4% |
|
GLAXOSMITHKLINE PLC-SPON ADR | -5.0% |
|
PFIZER INC | -4.7% |
 |
SANOFI-AVENTIS-ADR | -4.0% |
|
CENCORA INC | -3.9% |
|
ZOETIS INC | -3.3% |
 |
TAKEDA PHARMACEUTICAL CO. LTD. SPONS | -2.8% |